Back to Search
ALEXANDER GOTTLIEB, M.D.
M.D.
Anesthesiology Physician
NPI: 1952368284Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
35042945G(OH)
Research & Publications (20)
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
PMID 16488337·J Am Acad Dermatol·2006
3-trial
Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.
PMID 16488335·J Am Acad Dermatol·2006
1-meta
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
PMID 16081850·J Immunol·2005
8-other
Therapeutic options in the treatment of psoriasis and atopic dermatitis.
PMID 15968262·J Am Acad Dermatol·2005
6-review
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
PMID 15948985·Br J Dermatol·2005
3-trial
Alefacept is well tolerated in patients with chronic plaque psoriasis.
PMID 15668751·J Cutan Med Surg·2004
6-review
Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
PMID 15389187·J Am Acad Dermatol·2004
3-trial
Etanercept for the treatment of psoriasis and psoriatic arthritis.
PMID 15379775·Dermatol Ther·2004
6-review
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis.
PMID 15093549·Clin Immunol·2004
3-trial
Novel immunotherapies for psoriasis: clinical research delivers new hope for patients and scientific advances.
PMID 14870991·J Investig Dermatol Symp Proc·2004
6-review
A randomized trial of etanercept as monotherapy for psoriasis.
PMID 14676082·Arch Dermatol·2003
3-trial
CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study.
PMID 14576659·J Am Acad Dermatol·2003
3-trial
The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
PMID 12848110·J Drugs Dermatol·2003
3-trial
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.
PMID 12789171·J Am Acad Dermatol·2003
3-trial
Clinical research helps elucidate the role of tumor necrosis factor-alpha in the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes.
PMID 12708779·Lupus·2003
6-review
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris.
PMID 12522373·J Am Acad Dermatol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1952368284
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile